Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Last November the pharmaceutical giant agreed a $10 billion acquisition of the obesity-focused biopharma company Metsera, beating fellow market competitor Novo Nordisk after a lengthy contention.
Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor
Distinctly, both SGLT-2i and GLP-1RA significantly decreased the risk of cardiovascular events (odds ratios (OR)[95%CI], GLP1RA: 0.87[0.82-0.93]
In addition, the distribution and storage of a small molecule is less expensive, and scalability is simpler
US$ 20.33
US$ 27.63
US$ 29.44
US$ 26.26
US$ 22.54
US$ 27.64
